(E)-3-(3-Bromophenyl)-1-(4-methylphenyl)prop-2-en-1-one
暂无分享,去创建一个
[1] Suman Gupta,et al. Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents. , 2005, European journal of medicinal chemistry.
[2] H. S. Yathirajan,et al. (2E)-1-(2-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one , 2007 .
[3] K. Schønning,et al. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. , 2005, Journal of medicinal chemistry.
[4] N. Lawrence,et al. Linked parallel synthesis and MTT bioassay screening of substituted chalcones. , 2001, Journal of combinatorial chemistry.
[5] H. Fujita. [Anticancer drugs]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.
[6] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[7] J. Gut,et al. Synthesis and antimalarial activity of sulfonamide chalcone derivatives. , 2005, Farmaco.
[8] M. Conti. Cyclopentenone: a special moiety for anticancer drug design , 2006, Anti-cancer drugs.